![Markus Walter Sieger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus Walter Sieger
Directeur/Membre du Conseil chez
RAFAEL HOLDINGS, INC.
Fortune : 301 003 $ au 31/05/2026
Profil
Markus Walter Sieger is the founder of Iscoord AG.
Mr. Sieger is Chairman at Bioceros Holding BV since 2013.
Mr. Sieger is Director at Akrikhin Pharmaceuticals OAO since 2015.
Mr. Sieger is Director at Proceq SA since 2010.
Mr. Sieger is Director at Vektor AG since 2010.
Mr. Sieger is Director at BSP Pharmaceuticals SpA. Mr. Sieger is Lead Independent Director at Rafael Holdings, Inc. starting 2025.
Mr. Sieger is Managing Partner at Fincoord Finance Coordinators Ltd. since 1995.
Mr. Sieger is Member-Supervisory Board at Nutricia Polska Sp zoo.
Mr. Sieger is Member-Supervisory Board at Polfa Warszawa SA. Mr. Sieger is Principal at Consiglio AG since 2013.
Mr. Sieger is Member-Supervisory Board at Polpharma Group BV starting 2026.
Mr. Sieger is Principal at Sieger & Sieger Immobilien GmbH since 2013.
Mr. Sieger is Board Member at Fundacja Digital Poland since 2017.
Mr. Sieger is Board Member at Reaction Capital since 2020.
Mr. Sieger is Vice President at Medicines For Europe.
Formerly, Mr. Sieger was Chairman-Management Board & CEO at Polpharma SA. Mr. Sieger was Independent Director at Roust Corp.
from 2011 to 2013.
Mr. Sieger was Director at Grupa Onet SA. Mr. Sieger was Lead Independent Director at Cyclo Therapeutics, Inc. from 2014 to 2025.
Mr. Sieger was Member-Management Board at Mageba Holding AG.
Mr. Sieger was Member-Supervisory Board at Zaklady Tluszczowe Kruszwica SA. Mr. Sieger was Board Member at The ITI Group Ltd. from 2004 to 2013.
Mr. Sieger was Member-Supervisory Board at Medana Pharma SA. Mr. Sieger completed undergraduate studies at HWZ Hochschule für Wirtschaft Zürich.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/01/2026 | 219 710 ( 0,43% ) | 301 003 $ | 31/05/2026 |
Postes actifs de Markus Walter Sieger
| Sociétés | Poste | Début |
|---|---|---|
| RAFAEL HOLDINGS, INC. | Directeur/Membre du Conseil | 25/03/2025 |
Akrikhin Pharmaceuticals OAO
 Akrikhin Pharmaceuticals OAO Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 30/06/2015 |
Fundacja Digital Poland | Directeur/Membre du Conseil | 01/01/2017 |
Bioceros Holding BV
 Bioceros Holding BV Miscellaneous Commercial ServicesCommercial Services Develops monoclonal antibodies and generating GMP-ready cell lines | Président | 01/06/2013 |
Reaction Capital
 Reaction Capital Investment ManagersFinance Reaction invests in companies located across the globe. The firm targets companies operating in the fields of world health, environmental sustainability and Innovation Equity. It provides financing for early stage capital requirements. | Directeur/Membre du Conseil | 01/07/2020 |
Polpharma Group BV
 Polpharma Group BV Medical/Nursing ServicesHealth Services Provides healthcare services | Directeur/Membre du Conseil | 01/01/2026 |
Sieger & Sieger Immobilien GmbH | Corporate Officer/Principal | 01/01/2013 |
BSP Pharmaceuticals SpA
 BSP Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and manufactures anticancer drugs | Directeur/Membre du Conseil | - |
Fincoord Finance Coordinators Ltd. | Corporate Officer/Principal | 01/01/1994 |
| ░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Markus Walter Sieger
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Markus Walter Sieger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
25
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 25 |
|---|---|
Cyclo Therapeutics, Inc.
 Cyclo Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and sells cyclodextrins and related products | Health Technology |
Roust Corp.
 Roust Corp. Beverages: AlcoholicConsumer Non-Durables Produces and distributes vodka and other alcoholic beverages | Consumer Non-Durables |
Grupa Onet SA
 Grupa Onet SA Internet Software/ServicesTechnology Services Owns and operates a multimedia portal | Technology Services |
Mageba Holding AG
 Mageba Holding AG Metal FabricationProducer Manufacturing Provides bridge bearings and expansion joints | Producer Manufacturing |
Akrikhin Pharmaceuticals OAO
Akrikhin Pharmaceuticals OAO Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Polpharma SA
 Polpharma SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Zaklady Tluszczowe Kruszwica SA
 Zaklady Tluszczowe Kruszwica SA Agricultural Commodities/MillingProcess Industries Provides oilseed crushing, vegetable oil refining, packaging and marketing services | Process Industries |
Fincoord Finance Coordinators Ltd. | |
Nutricia Polska Sp zoo
 Nutricia Polska Sp zoo Food DistributorsDistribution Services Engages in sale of nutritional food | Distribution Services |
Proceq SA
 Proceq SA Electronic Equipment/InstrumentsElectronic Technology Mnufactures portable testing instruments for metal hardness, concrete properties and paper roll hardness | Electronic Technology |
Vektor AG
 Vektor AG Industrial MachineryProducer Manufacturing Develops and manufactures hydraulics and pneumatics equipment | Producer Manufacturing |
HWZ Hochschule für Wirtschaft Zürich
 HWZ Hochschule für Wirtschaft Zürich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BSP Pharmaceuticals SpA
BSP Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology Develops and manufactures anticancer drugs | Health Technology |
Medana Pharma SA
 Medana Pharma SA Medana Pharma SA engages in the production of pharmaceutical substances. It offers vitamins and herbal products. The company was founded in 1956 and is headquartered in Sieradz, Poland. | |
Polfa Warszawa SA
 Polfa Warszawa SA Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceutical products | Health Technology |
Iscoord AG | |
Consiglio AG | |
Bioceros Holding BV
Bioceros Holding BV Miscellaneous Commercial ServicesCommercial Services Develops monoclonal antibodies and generating GMP-ready cell lines | Commercial Services |
The ITI Group Ltd.
 The ITI Group Ltd. Investment ManagersFinance Provides investment service | Finance |
Rafael Holdings, Inc.
 Rafael Holdings, Inc. Real Estate DevelopmentFinance Operates as holding company with interest in real estate and pharmaceutical sector | Finance |
Medicines For Europe
 Medicines For Europe Miscellaneous Commercial ServicesCommercial Services Operates as representative for medicine industry | Commercial Services |
Polpharma Group BV
Polpharma Group BV Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Sieger & Sieger Immobilien GmbH | |
Fundacja Digital Poland | |
Reaction Capital
Reaction Capital Investment ManagersFinance Reaction invests in companies located across the globe. The firm targets companies operating in the fields of world health, environmental sustainability and Innovation Equity. It provides financing for early stage capital requirements. | Finance |
